Tag: automation in biopharma industry market trends

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Automation In Biopharma Industry Market From 2025 To 2034?

The automation in biopharma industry market has demonstrated strong expansion in recent years. It is anticipated to increase from $2.08 billion in 2024 to $2.19 billion in 2025, with a compound annual growth rate (CAGR) of 5.6%. The historical surge in this market can be linked to factors such as the heightened complexity in biopharmaceutical processes, the necessity for improved process efficiency, the expansion in biologics development and manufacturing, the demand for stringent quality assurance and control, and the urgency to reduce time-to-market.

The market size for automation in the biopharma industry is predicted to experience significant expansion over the next few years. It is expected to reach “$2.92 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.4%. This anticipated growth is driven by factors such as improved data integrity and documentation, the increasing prevalence of personalized medicine, the rise of modular and flexible bioprocessing facilities, the evolution of automation platforms, a surging demand for biosimilars, and the adoption of smart sensors and the Internet of Things (IoT). Prominent trends during this forecast period include advancements in robotics and automation technologies, innovations in single-use technologies, the integration of artificial intelligence in bioprocessing, progress in process analytical technologies (PAT), enhanced collaboration between biopharma and technology companies, and a heightened emphasis on sustainability in biopharma automation.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

What Are The Drivers Pushing New Developments In The Automation In Biopharma Industry Market?

The widespread integration of robots in pharmaceutical manufacturing is anticipated to drive the expansion of the automation in biopharma industry market. Robots employed in pharmaceutical production are advanced automated systems and machines that perform various functions in the creation and packaging of pharmaceutical products. These robots are frequently utilized in multiple applications within pharmaceutical manufacturing, such as secondary packaging, intralogistics, laboratory automation, pick and place operations, automation of pharmacy processes, and personalized medicine, leading to increased productivity, enhanced precision, reduced contamination risk, and improved worker safety. For instance, in September 2024, data from the International Federation of Robotics, a Germany-based professional non-profit organization, indicated that industrial robot installations in the manufacturing industry in Europe surged by 9%, hitting a record high of 92,393 units. Out of these, 80% were installed within the European Union, totaling 73,534 units—a 2% increase from the prior year. Therefore, the growing adoption of robots in pharmaceutical manufacturing will fuel the growth of the automation in biopharma industry market.

What Are The Major Segment Categories Driving The Automation In Biopharma Industry Market Growth?

The automation in biopharma industrymarket covered in this report is segmented –

1) By Technology: Automation Technology; Digitization Technology

2) By Component: Automation Hardware; Automation Software; Services Project Phase; Services Operation Phase

3) By Application: Clinical Phase; Drug Discovery Phase; Production Phase

Subsegments:

1) By Automation Technology: Process Automation; Laboratory Automation; Robotics And Artificial Intelligence; Control Systems; Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization; Electronic Lab Notebooks (ELN); Cloud Computing; Internet Of Things (IoT) In Pharma; Digital Twin Technology

Which Trends Are Impacting The Automation In Biopharma Industry Market?

Technological advancements are a prominent trend gaining traction in the automation within the biopharma industry market. Major companies operating in the automation in biopharma industry market are focused on developing cutting-edge product technologies to strengthen their presence in the market. For instance, in September 2022, PerkinElmer Inc., a US-based company offering scientific solutions and technologies, launched the Cellaca PLX Image Cytometry System, an innovative automated cell analysis solution designed to streamline cell and gene therapy research and manufacturing processes. The Cellaca PLX platform allows researchers to evaluate vital quality attributes of cell samples, including identity, quantity, and quality, through an automated workflow. This integrated system merges image cytometer hardware, software, validated consumables, and trackable data reporting, thereby simplifying calibration and training requirements.

Which Leading Players Are Enhancing Their Automation In Biopharma Industry Market Presence Worldwide?

Major companies operating in the automation in biopharma industry market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

What Are The Regional Market Dynamics Impacting The Automation In Biopharma Industry Industry?

North America was the largest region in the automation in biopharma industry market in 2024. The regions covered in the automation in biopharma industry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Automation In Biopharma Industry Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12704&type=smp

Browse Through More Reports Similar to the Global Automation In Biopharma Industry Market 2025, By The Business Research Company

Biopharmaceutical Cmo Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-global-market-report

Biopharmaceuticals Contract Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biopharmaceuticals-contract-manufacturing-global-market-report

Lyophilization Services For Biopharmaceuticals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lyophilization-services-for-biopharmaceuticals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Automation In Biopharma Industry Market Size from 2025 to 2034?

The biopharma industry’s automation market size has seen robust growth in recent periods. A rise from $2.08 billion in 2024 to $2.19 billion in 2025 is projected, indicating a compound annual growth rate (CAGR) of 5.6%. The previous growth is associated with factors such as the escalating complexity in biopharmaceutical procedures, the necessity for enhanced process efficiency, expansion in biologics production and development, the demand for quality assurance and control, and the compulsion to mitigate time-to-market.

In the coming years, the automation market in the biopharma industry is projected to experience substantial growth, reaching a tremendous value of $2.92 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 7.4%. The anticipated growth within this forecast period can be accredited to improved integrity and documentation of data, the emerging trend of personalized medicine, the arrival of flexible and modular bioprocessing facilities, the advancement of automation platforms, increased demand for biosimilars, and the deployment of smart sensors and Internet of Things (IoT). Key shifts during the forecast period encompass leaps forward in robotics and automation technologies, advances in single-use technologies, the application of artificial intelligence in bioprocessing, progression in process analytical technologies (pat), synergies between biopharma and tech firms, and a focus on sustainability in biopharma automation.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

What External and Internal Drivers Are Contributing to the Growth of theAutomation In Biopharma Industry Market?

The growth of the automation in the biopharma industry market is anticipated to be fuelled by the rising utilisation of robots in pharmaceutical manufacturing. These robots, sophisticated automated machines and systems, are involved in various tasks of production and packaging of pharmaceutical products. Such tasks may involve secondary packaging, intralogistics, laboratory automation, pick and place, pharmacy processes automation, and personalized medicine, leading to increased productivity, precision enhancement, lowered contamination risk, and heightened safety for workers. For example, in September 2024, the International Federation of Robotics, a professional non-profit organization located in Germany, reported a 9% increase in industrial robot installations in the manufacturing industry in Europe, achieving a historic peak of 92,393 units. Of this total, 80%, or 73,534 units, were installed within the European Union, indicating a 2% growth from the prior year. Consequently, the surge in the utilisation of robots in pharmaceutical manufacturing is expected to contribute towards the growth of the automation in the biopharma industry market.

What Segment Types Define the Automation In Biopharma Industry Market Structure?

The automation in biopharma industrymarket covered in this report is segmented –

1) By Technology: Automation Technology; Digitization Technology

2) By Component: Automation Hardware; Automation Software; Services Project Phase; Services Operation Phase

3) By Application: Clinical Phase; Drug Discovery Phase; Production Phase

Subsegments:

1) By Automation Technology: Process Automation; Laboratory Automation; Robotics And Artificial Intelligence; Control Systems; Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization; Electronic Lab Notebooks (ELN); Cloud Computing; Internet Of Things (IoT) In Pharma; Digital Twin Technology

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12704&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Automation In Biopharma Industry Market?

North America was the largest region in the automation in biopharma industry market in 2024. The regions covered in the automation in biopharma industry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Long-Term Trends Are Transforming the Competitive Landscape of the Automation In Biopharma Industry Market?

Innovations in technology are becoming a driving factor in the automation in the biopharma industry market. To fortify their standing in the market, top-tier firms operating in the sector are concentrating on the creation of advanced product technologies. An example of this was seen in September 2022 when PerkinElmer Inc., a US-based scientific solutions and technologies provider, introduced the Cellaca PLX Image Cytometry System. This is a state-of-the-art automated cell analysis solution intended to streamline the research and manufacturing processes of cell and gene therapy. The Cellaca PLX platform provides researchers with the ability to assess crucial quality attributes of cell samples such as identity, quantity, and quality, through an automated workflow. This comprehensive system fuses image cytometer hardware, software, validated consumables, and traceable data reporting, making the calibration and training processes more manageable.

View the full report here:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

What Is the Definition of the Automation In Biopharma Industry Market?

Automation in the biopharma industry refers to integrating advanced technologies and robotics into various stages of the biopharmaceutical manufacturing process. It includes using automated systems and equipment to carry out tasks traditionally performed by humans, intending to increase efficiency, accuracy, and productivity in producing biopharmaceutical products.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12704

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Automation In Biopharma Industry Market Growth in 2025?

The biopharma industry’s market size for automation has seen significant growth in recent years. The market is projected to expand from $2.08 billion in 2024 to $2.2 billion in 2025, with a compound annual growth rate (CAGR) of 5.9%. The historical growth can be credited to the compounded complexities in biopharmaceutical processes, the necessity for enhanced process efficiency, the surge in the development and manufacturing of biologics, the demand for quality assurance and control, and the urgency to decrease time-to-market.

What Is the Forecast for the Automation In Biopharma Industry Market Size Through 2029?

In the coming years, robust growth is anticipated in the automation market within the biopharma industry. The market size is predicted to expand to $2.92 billion by 2029, boasting a compound annual growth rate (CAGR) of 7.4%. The projected growth during this period is attributable to several factors, including improved data integrity and documentation, the emergence of personalized medicine, development of modular and flexible bioprocessing facilities, evolution of automation platforms, escalating demand for biosimilars, and the implementation of smart sensors and the internet of things (iot). Significant trends during the forecast period are expected to involve progress in robotics and automation technologies, advancements in single-use technologies, artificial intelligence integration in bioprocessing, enhancement in process analytical technologies (pat), collaborations between biopharma and technology firms, and a focus on sustainability in biopharma automation.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

What are the Key Market Players in Automation In Biopharma Industry Market and How They’re Evolving?

Major companies operating in the automation in biopharma industry market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

What Are the Primary Growth Drivers in the Automation In Biopharma Industry Market?

The growth of the automation market in the biopharma industry is likely to be fueled by the rising use of robots in pharmaceutical manufacturing. This refers to the use of sophisticated automated systems and machines capable of carrying out a variety of tasks in the production and packaging of pharmaceutical products. Robots are deployed in a multitude of pharmaceutical manufacturing applications, such as secondary packaging, intralogistics, laboratory automation, pick and place, pharmaceutical process automation, and personalized medicine. This results in increased productivity, enhanced accuracy, lower contamination risk, and better safety for workers. The International Federation of Robotics, a non-profit professional organization based in Germany, reported in September 2024 that there had been a 9% rise in industrial robot installations in the manufacturing industry in Europe, reaching a record of 92,393 units. Among these, 80% or 73,534 units were installed within the European Union, marking a 2% increase from the prior year. As such, the growth of the biopharma industry automation market is likely to be triggered by the escalating use of robots within pharmaceutical manufacturing.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12704&type=smp

What Are the Leading Segments in the Global Automation In Biopharma Industry Industry?

The automation in biopharma industry market covered in this report is segmented –

1) By Technology: Automation Technology, Digitization Technology

2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase

3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:

1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

What Are the Key Market Trends in the Automation In Biopharma Industry Industry?

The emergence of technological innovations is a notable trend that is gaining traction in the automation in biopharma industry market. Leading firms in this sector are channeling their efforts to develop revolutionary product technologies to consolidate their market foothold. For example, PerkinElmer Inc., a company based in the U.S. renowned for providing scientific solutions and technologies, rolled out the Cellaca PLX Image Cytometry System, an advanced automated cell analysis solution, in September 2022. This novel solution was crafted to streamline cell and gene therapy research and production. The Cellaca PLX platform is engineered to allow researchers to examine critical quality characteristics of cell samples, such as their identity, quantity, and quality, utilizing an automated procedure. This comprehensive system fuses image cytometer equipment, software, validated consumables, and traceable data reporting, thereby simplifying calibration and training necessities.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

What Is the Regional Outlook for the Automation In Biopharma Industry Market?

North America was the largest region in the automation in biopharma industry market in 2024. The regions covered in the automation in biopharma industry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12704

This Report Delivers Insight On:

1. How big is the automation in biopharma industry market, and how is it changing globally?

2. Who are the major companies in the automation in biopharma industry market, and how are they performing?

3. What are the key opportunities and risks in the automation in biopharma industry market right now?

4. Which products or customer segments are growing the most in the automation in biopharma industry market?

5. What factors are helping or slowing down the growth of the automation in biopharma industry market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the automation in biopharma industry industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Anticipated CAGR of the Automation In Biopharma Industry Market, and What Factors Will Drive It?

The market size of automation in the biopharma industry has seen robust growth in the past few years. The market, which is predicted to escalate from $2.08 billion in 2024 to $2.2 billion in 2025, is expected to witness a compound annual growth rate (CAGR) of 5.9%. This expansion during the historical period can be linked to factors like rising complexity in biopharmaceutical procedures, the necessity for enhanced process efficiency, increase in biologics’ production and development, the need for quality assurance and control, and the pressure to decrease the time-to-market.

Anticipated to experience robust growth in the coming years, the automation in biopharma industry market is projected to expand to $2.92 billion by 2029, with a compound annual growth rate (CAGR) of 7.4%. Factors contributing to this expansion in the forecast period include improvements in data integrity and documentation, the emergence of personalized medicine, development of modular and flexible bioprocessing facilities, advancement of automation platforms, increased demand for biosimilars, and the adoption of smart sensors and the internet of things (IoT). The forecast period will also see major trends such as progress in robotics and automation technologies, breakthroughs in single-use technologies, incorporation of artificial intelligence in bioprocessing, progress in process analytical technologies (PAT), partnerships between biopharma and tech firms, and a greater focus on sustainability in biopharma automation.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

Which Factors and External Forces Are Driving Demand in the Automation In Biopharma Industry Market?

The uptake of robots in the manufacturing of pharmaceuticals is set to fuel the growth of the automation market in the biopharma sector. Products and processes in pharmaceutical production are increasingly being carried out by sophisticated automatic systems and machines, commonly referred to as robots. These robots are employed in a variety of applications such as secondary packaging, intralogistics, laboratory automation, pick and place, pharmacy process automation, and personalised medicine. The end result of this is heightened productivity, increased precision, diminished risk of contamination and superior worker safety. Citing an example, the International Federation of Robotics, a German-based non-profit professional group, revealed in September 2024 that there was a 9% rise in industrial robot installations in the manufacturing industry across Europe to reach an all-time high of 92,393 units. Out of this figure, 80% or 73,534 units were installed within the European Union, marking a 2% increase from the year prior. Consequently, as the use of robots in pharmaceutical manufacturing amplifies, so too will the growth of the biopharma industry’s automation market.

Which Segments in the Automation In Biopharma Industry Offer the Most Growth?

The automation in biopharma industry market covered in this report is segmented –

1) By Technology: Automation Technology, Digitization Technology

2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase

3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:

1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12704&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Automation In Biopharma Industry Market?# Market?

North America was the largest region in the automation in biopharma industry market in 2024. The regions covered in the automation in biopharma industry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Cutting-Edge Market Trends Are Expected to Drive theAutomation In Biopharma Industry Market’s Growth?

Innovations in technology are increasingly making their mark as a top trend in the automation in biopharma industry market. A large number of companies in this sector are prioritizing the development of technologically advanced products to solidify their market standing. For instance, PerkinElmer Inc., a company based in the U.S. that offers scientific technologies and solutions, rolled out the Cellaca PLX Image Cytometry System, an avant-garde automated cell analysis tool, in September 2022. This product is tailored to streamline cell and gene therapy research and manufacturing. The Cellaca PLX platform facilitates researchers’ analysis of crucial quality attributes of cell samples such as identity, quantity, and quality, via an automated process. This all-inclusive system merges image cytometer hardware, software, validated consumables, and trackable data reporting, making calibration and training easier.

View the full report here:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

What Are the Key Elements That Define the Automation In Biopharma Industry Market?

Automation in the biopharma industry refers to integrating advanced technologies and robotics into various stages of the biopharmaceutical manufacturing process. It includes using automated systems and equipment to carry out tasks traditionally performed by humans, intending to increase efficiency, accuracy, and productivity in producing biopharmaceutical products.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12704

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theAutomation In Biopharma Industry Market?

The anticipated acceleration in the use of robots in pharmaceutical production will likely spur development in the automation sector of the biopharma industry market. Robots in this context refer to progressive automated machines and systems engineered to carry out various tasks in the creation and packaging of pharmaceutical products. Robots have found multiple applications in pharmaceutical production including secondary packaging, intralogistics, lab automation, pick and place, pharmacy process automation, and personalized medicine. These applications boost productivity, improve precision, decrease contamination risks, and enhance worker safety. For example, in September 2024, the Germany-based, non-profit professional body, International Federation of Robotics, reported that industrial robot installations in the European manufacturing industry saw an increase of 9%, setting a new record at 92,393 units. Of these installations, 80% (equating to 73,534 units) were established within the European Union, marking a 2% increase from the preceding year. As such, the rising use of robots in pharmaceutical production is predicted to bolster the growth of the automation in biopharma industry market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

#What is the Anticipated CAGR of theAutomation In Biopharma Industry Market, and What Factors Will Drive It?

There has been significant growth in the market size of automation in the biopharma industry in past years. It is predicted to expand from $2.08 billion in 2024 to $2.2 billion in 2025, signifying a compound annual growth rate (CAGR) of 5.9%. The robust growth during the historical period was due to various factors such as the rise in complexity of biopharmaceutical procedures, the necessity for enhanced process proficiency, growth in the development and manufacturing of biologics, the demand for assurance and control of quality, and the urgency to lessen the time-to-market.

The market for automation in the biopharma industry is projected to witness robust expansion in the coming years, expecting to surge to $2.92 billion by 2029, with a compound annual growth rate (CAGR) of 7.4%. Various factors contributing to this projected growth during the forecast period include improved data integrity and documentation, the emergence of personalized medicine, the development of modular and flexible bioprocessing facilities, the progression of automation platforms, increasing demand for biosimilars, and the implementation of smart sensors and internet of things (IoT). Major trends predicted for the forecast period encompass breakthroughs in robotics and automation technologies, progress in single-use technologies, the incorporation of artificial intelligence in bioprocessing, advancements in process analytical technologies (PAT), collaborations between biopharma and tech companies, and a focus on sustainability in biopharma automation.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12704

Which Cutting-Edge Market Trends Are Expected to Drive theAutomation In Biopharma Industry Market’s Growth?

The surge in technological innovations stands as a fundamental trend in the automation within the biopharma industry market. For the key players in this sector, introducing cutting-edge product technologies is a strategic move to solidify their market stance. An apt example of this progress is PerkinElmer Inc., an American firm known for its scientific solutions and technologies. In September 2022, the company rolled out the Cellaca PLX Image Cytometry System, an innovative automated cell analysis solution crafted to streamline cell and gene therapy research and development processes. This platform enables researchers to efficiently evaluate key quality aspects of cell samples such as identity, amount, and quality, through an automated process. The integrated system harmonizes image cytometer tools, software, validated consumables, and easily traceable data reporting, thus reducing the complexities associated with calibration and training.

What Are the Leading Market Players Impacting theAutomation In Biopharma Industry Market’s Growth Trend?

Major companies operating in the automation in biopharma industry market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

How Are the Key Segments of the Automation In Biopharma Industry Market Driving Opportunities and Innovations?

The automation in biopharma industry market covered in this report is segmented –

1) By Technology: Automation Technology, Digitization Technology

2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase

3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:

1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12704&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theAutomation In Biopharma Industry Market?# Market Expansion?

North America was the largest region in the automation in biopharma industry market in 2024. The regions covered in the automation in biopharma industry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Automation In Biopharma Industry Maret 2025, By The Business Research Company:

Industrial Automation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/industrial-automation-global-market-report

Logistics Automation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/logistics-automation-global-market-report

Process Automation and Instrumentation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/process-automation-and-instrumentation-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the automation in biopharma industry market size evolved in recent years?

The market size of automation in the biopharma industry has seen robust growth over the past few years. It is projected to expand from a value of $2.08 billion in 2024 to $2.2 billion in 2025, with a compound annual growth rate (CAGR) of 5.9%. Factors contributing to the growth during the historic period include increased complexity in biopharmaceutical procedures, a need for enhanced process efficiency, expansion in biologics development and manufacturing, and demand for quality assurance and control, as well as the pressure to reduce time-to-market.

What are the predictions for the automation in biopharma industry market size in the coming years?

Projections show robust expansion in the automation within the biopharma industry market size in the subsequent years. By 2029, it’s expected to reach the valuation of $2.92 billion with a compound annual growth rate (CAGR) of 7.4%. This predicted growth over the forecast period can be linked to improved documentation and data integrity, the emerging trend of personalized medicine, the advent of adaptable and modular bioprocessing units, the evolution of automation platforms, burgeoning demand for biosimilars, and the utilization of smart sensors along with the Internet of Things (IoT). Significant trends throughout the forecast span consist of advancements in automated robotic technologies, lead forward in single-use processes, implementation of artificial intelligence in bioprocessing, progress in process analytical tech (PAT), cooperation between biopharma and tech firms, and focus on sustainability in biopharma automation.

Get your automation in biopharma industry market report here!

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

What key factors are fueling the growth of the automation in biopharma industry market?

The rise in utilization of robots within pharmaceutical manufacturing is predicted to accelerate the expansion of automation in the biopharma industry market. Advanced automated systems and machines, known as robots, are employed in various roles to create and package pharmaceutical products. They find use in numerous applications in the pharmaceutical manufacturing space such as intralogistics, secondary packaging, lab automation, pick and place operations, pharmacy process automation, and personalized medicine. This results in superior productivity, heightened accuracy, diminished chances of contamination, and better safety for employees. For example, data from the Germany-based International Federation of Robotics showed that in September 2024, industrial robot installations within Europe’s manufacturing industry witnessed a 9% surge, setting a new record of 92,393 units. Out of these, 80%, or 73,534 units, were set up within the European Union, marking a 2% increase from the year before. Hence, the rising use of robots within pharmaceutical manufacturing is expected to fuel the expansion of the automation in the biopharma industry market.

How is the global automation in biopharma industry market divided into key segments?

The automation in biopharma industry market covered in this report is segmented –

1) By Technology: Automation Technology, Digitization Technology

2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase

3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:

1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

Who are the key firms paving the way for growth in the automation in biopharma industry market?

Major companies operating in the automation in biopharma industry market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

Which trends are expected to transform the automation in biopharma industry market?

Innovations in technology are a leading trend garnering attention in the biopharmaceutical automation industry. The major corporations in this market are concentrating on the development of advanced technological products to bolster their market presence. For example, PerkinElmer Inc., a scientific solution and technology provider based in the US, introduced the Cellaca PLX Image Cytometry System, an innovative automated cell analysis solution, in September 2022. This was created to streamline cell and gene therapy research and production. The Cellaca PLX platform empowers researchers with the ability to assess fundamental attributes of cell samples, like identity, volume and quality, via an automated procedure. This comprehensive system merges image cytometer hardware, software, validated consumables and traceable data reporting, making calibration and training processes less complicated.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12704

What regions are contributing significantly to the growth of the automation in biopharma industry market?

North America was the largest region in the automation in biopharma industry market in 2024. The regions covered in the automation in biopharma industry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Industrial Automation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/industrial-automation-global-market-report

Logistics Automation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/logistics-automation-global-market-report

Process Automation and Instrumentation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/process-automation-and-instrumentation-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: